ArticleScientific reports2018

The soluble guanylate cyclase stimulator riociguat reduces fibrogenesis and portal pressure in cirrhotic rats.

Philipp Schwabl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.